Economic evaluation with clinical trials in neonatology

NeoReviews

Volumn 12, Issue 2, 2011, Pages

  Dukhovny, Dmitry ^a   Zupancic, John A F ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959875761     PISSN: None     EISSN: 15269906     Source Type: Journal    
DOI: 10.1542/neo.12-2-e69     Document Type: Article

References (15)

1. Doshi JA, Glick HA, Polsky D. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials. Value Health. 2006;9:334-340
2. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996;313:275-283
3. Drummond MF, Schwartz JS, Jonsson B, et al. Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24:244-258
4. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddard GL. Methods for the Economic Evaluation of Health Care Programs. 3rd ed. Oxford, United Kingdom: Oxford University Press; 2005
5. Glick HA, Doshi JA., Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. New York, NY: Oxford Press; 2007
6. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. Oxford, United Kingdom: Oxford University Press; 1996
7. Hunink MGM, Glasziou PP, Siegel JE, et al. Decision Making in Health and Medicine: Integrating Evidence and Values. Cambridge, United Kingdom: Cambridge University Press; 2001
8. Medical Care. 2009;47(supplement 7_1). [The entire supplement is dedicated to methodology in cost-effectiveness analyses]
9. Ramsey S, Willke R, Briggs A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health. 2005;8:521-533
10. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. JAMA. 1997;276:1172-1177
11. Saigal S, Tyson J. Measurement of quality of life of survivors of neonatal intensive care: critique and implications. Semin Perinatol. 2008;32:59-66
12. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. JAMA. 1996;276: 1339-1341
13. Weinstein MC, O'Brien B, Hornberger J, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices-Modeling Studies. Value Health. 2003;6:9-17
14. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276:1253-1258
15. Zupancic JAF. Appendix D. A systematic review of costs associated with preterm birth. In: Institute of Medicine. Preterm Birth: Causes, Consequences, and Prevention. Washington DC: National Academies Press; 2007